2025 Symposium Supporters
Premier Level Supporters
              Alexandria
Gold Level Supporters
              BostonGene
              Bristol Myers Squibb
              Foundation Medicine
              Inhibrx
              LifeSci Communications
              Lilly
              Varian, a Siemens Healthineers Company
Silver Level Supporters
              Johnson & Johnson
              Novartis
Bronze Level Supporters
      Avalon BioVentures
      Cardiff Oncology
      Caris Life Sciences
      Crown Bioscience
      Exelixis
Susan and David KABAKOFF
      Kura Oncology
      Lantheus
      Natera
      Neomorph
      Pfizer
      Radformation
      Z-Alpha
Anonymous
Supporters
      Alkyon Therapeutics
      Ionis Pharmaceuticals
      Monoceros Biosystems
      Treeline Biosciences
      Yatiri Bio
Potential Supporters
If you would like to support the 2025 Symposium, please contact Ida at ideichaite@ucsd.edu.
Special Thanks to our Past Supporters
The Symposium would not be possible without support from the San Diego ecosystem and biotech community.
We share a heartfelt thanks to our past supporters:  2024 Supporters (PDF)  |    2023 Supporters (PDF)
 
COI Policy: Disclosure of Relationships with Companies
The Symposium strives for independence, objectivity, transparency, and scientific rigor in all its activities through appropriate disclosure and management of financial relationships, among other things. The Symposium Policy for Relationships with Companies (COI Policy), in compliance with UC San Diego and University of California Office of the President (UCOP) COI policies (available at this link), was developed to help guide the management of potential conflicts, primarily through disclosure of all financial relationships that might result in actual, potential, or perceived conflicts of interest.
The Symposium requires participants in its activities—and all faculty and committee members— to disclose all of their financial relationships with for-profit health care companies. The Symposium’s Policy is not intended to create a presumption of impropriety based on the existence of financial relationships with companies, rather the goal is to achieve full transparency through the disclosure of those relationships. Although the Symposium Policy relies primarily on disclosure of financial relationships, it also recognizes that some relationships cannot be managed with disclosure alone and identifies additional management steps in this case.
The Symposium wants to help participants in its activities to successfully report their disclosures. To that end, the Symposium uses a general disclosure model, requiring disclosure of all relationships.  
